Genes Coding for Tumor-specific Rejection Antigens

  1. T. Boon,
  2. B. Van den Eynde,
  3. H. Hirsch*,
  4. C. Moroni*,
  5. E. De Plaen,
  6. P. van der Bruggen,
  7. C. De Smet,
  8. C. Lurquin,
  9. J.-P. Szikora, and
  10. O. De Backer
  1. Ludwig Institute for Cancer Research, Brussels Branch, B1200 Brussels, Belgium, and Cellular Genetics Unit, Université Catholique de Louvain, B1200 Brussels, Belgium; *Institute for Medical Microbiology, University of Basel, CH-4053 Basel, Switzerland

This extract was created in the absence of an abstract.

Excerpt

Mouse tumors induced with chemical carcinogens or UV light are immunogenic: Tumor cells killed by irradiation or living tumor cells later removed by surgery confer to the inoculated animal a lasting protection against a challenge with the same tumor cells (Klein et al. 1960; Kripke and Fisher 1976). This specific protection was the first evidence for the existence of specific tumor rejection antigens. T lymphocytes were shown to carry the specific memory involved in these responses. Later, it became apparent that many tumors, including most, if not all, spontaneous tumors, do not elicit any immune rejection response (Hewitt et al. 1976). However, from such nonimmunogenic tumor cell lines that were treated in vitro with a mutagen, it was possible to derive variants that expressed potent new antigens (Van Pel et al. 1983). These “tum” variants were rejected by syngeneic mice, and these mice were protected against a challenge with the...

| Table of Contents